TESTBANK FOR ROACHES INTRODUCTORY CLINICAL
|! |! |! |!
PHARMACOLOGY 11TH EDITION
|! |! |!
1. A |!nursing |!instructor |!is |!preparing |!a |!teaching |!plan |!for |!a |!group |!of |!nursing |!students
|!about |!pharmacology. |!When |!describing |!this |!topic, |!the |!instructor |!would |!focus |!the
|!discussion |!on |!which |!of |!the |!following |!as |!an |!essential |!aspect?
A) Drug |!name
B) Drug |!class
C) Drug |!action
D) Drug |!source
|!Ans: | ! C
|!Feedback:
Pharmacology |!is |!the |!study |!of |!drugs |!and |!their |!action |!on |!living |!organisms. |!Thus, |!an
|!essential |!aspect |!of |!pharmacology |!is |!drug |!action. |!An |!understanding |!of |!the |!drug |!name,
|!drug |!class, |!and |!drug |!source |!is |!important, |!but |!the |!most |!critical |!aspect |!related |!to
|!pharmacology |!is |!how |!the |!drug |!acts |!in |!the |!body.
2. A |!nursing |!student |!is |!preparing |!to |!administer |!a |!prescribed |!drug |!to |!a |!patient. |!The
|!student |!reviews |!information |!about |!the |!drug |!and |!its |!actions. |!Which |!of |!the |!following
|!would |!be |!the |!best |!choice |!for |!obtaining |!this |!information? |!Select |!all |!that |!apply.
A) Nursing |!instructor
B) Nurse |!assigned |!to |!the |!patient
C) Clinical |!drug |!reference
D) Prescribing |!health |!care |!provider
E) Clinical |!pharmacist
|!Ans: |!C, |!E
Feedback:
Although |!the |!nursing |!student |!can |!ask |!the |!nursing |!instructor, |!the |!nurse |!assigned |!to |!the
|!patient, |!and |!the |!prescribing |!health |!care |!provider |!for |!information |!about |!the |!drug, |!the
|!best |!choices |!for |!drug |!information |!would |!include |!an |!appropriate |!drug |!reference |!and
|!the |!clinical |!pharmacist.
3. When |!describing |!the |!various |!types |!of |!medications |!to |!a |!group |!of |!nursing |!students,
|!a |!nursing |!instructor |!would |!identify |!which |!of |!the |!following |!as |!a |!source |!for
|!deriving |!medications? |!Select |!all |!that |!apply.
A) Plants
B) Synthetic |!sources
C) Mold
D) Minerals
E) Animals
|!Ans: |!A, |!B, |!C, |!D,
|!E
Feedback:
Medications |!are |!derived |!from |!natural |!sources, |!for |!example, |!plants, |!molds, |!minerals, |!and
|!animals, |!as |!well |!as |!created |!synthetically |!in |!a |!laboratory.
Page | ! 1 WWW.THENURSINGMASTERY.COM
,TESTBANK |!FOR |!ROACHES |!INTRODUCTORY |!CLINICAL |!PHARMACOLOGY |!11TH |!EDITION
4. Which |!of |!the |!following |!names |!may |!be |!assigned |!to |!a |!drug |!during |!the |!process
|!of |!development? |!Select |!all |!that |!apply.
A) Chemical |!name
B) Official |!name
C) Pharmacologic |!name
D) Trade |!name
E) Nonproprietary|!name
|!Ans: | ! A, |!B, |!D, |!E
Feedback:
Throughout |!the |!process |!of |!development, |!drugs |!may |!have |!several |!names |!assigned |!to
|!them |!including |!a |!chemical |!name, |!a |!generic |!(nonproprietary) |!name, |!an |!official |!name,
|!and |!a |!trade |!or |!brand |!name.
5. A |!drug |!may |!be |!classified |!by |!which |!of |!the |!following? |!Select |!all |!that |!apply.
A) The |!chemical |!type |!of |!the |!drug's |!active |!ingredient
B) The |!way |!the |!drug |!is |!used |!to |!treat |!a |!specific |!condition
C) The |!generic |!name |!of |!the |!drug
D) The |!trade |!name |!of |!the |!drug
E) The |!nonproprietary |!name |!of |!the |!drug
|!Ans: |!A, |!B
Feedback:
A |!drug |!may |!be |!classified |!by |!the |!chemical |!type |!of |!the |!active |!ingredient |!or |!by |!the |!way |!it
|!is |!used |!to |!treat |!a |!particular |!condition. |!Generic, |!trade, |!and |!nonproprietary |!refer |!to |!how
|!a |!drug |!is |!named.
6. A |!group |!of |!nursing |!students |!are |!reviewing |!information |!about |!the |!process |!of |!drug
|!development |!in |!the |!United |!States. |!The |!students |!demonstrate |!understanding |!of |!this
|!process |!when |!they |!identify |!that |!which |!of |!the |!following |!categories |!are |!assigned |!by
|!the |!Food |!and |!Drug |!Administration |!to |!newly |!approved |!drugs? |!Select |!all |!that |!apply.
A) Metabolite
B) Noncontrolled |!substance
C) Prescription
D) Nonprescription
E) Controlled |!substance
|!Ans: |!C, |!D, |!E
Feedback:
Once |!drugs |!are |!approved |!for |!use, |!the |!FDA |!assigns |!the |!drug |!to |!one |!of |!the |!following
|!categories: |!prescription, |!nonprescription, |!or |!controlled |!substance. |!Metabolite |!refers |!to
|!the |!inactive |!form |!of |!the |!drug. |!Noncontrolled |!substance |!is |!a |!term |!that |!is |!not |!used.
Page | ! 2 WWW.THENURSINGMASTERY.COM
,TESTBANK |!FOR |!ROACHES |!INTRODUCTORY |!CLINICAL |!PHARMACOLOGY |!11TH |!EDITION
7. Which |!of |!the |!following |!would |!be |!most |!important |!for |!the |!nurse |!to |!do |!to |!ensure |!the
|!safe |!use |!of |!prescription |!drugs |!in |!the |!institutional |!setting? |!Select |!all |!that |!apply.
A) Administering |!drugs
B) Monitoring |!clients |!for |!drug |!effects
C) Prescribing |!drugs
D) Evaluating |!clients |!for |!toxic |!effects
E) Educating |!clients/caregivers |!about |!drugs
|!Ans: |!A, |!B, |!D, |!E
Feedback:
In |!the |!institutional |!setting, |!the |!nurse's |!role |!to |!ensure |!safe |!use |!of |!prescription |!drugs
|!includes |!administering |!drugs, |!monitoring |!drug |!effects, |!evaluating |!for |!toxic |!effects, |!and
|!educating |!clients |!and |!caregivers |!about |!drugs.
8. The |!nurse |!is |!helping |!a |!client |!review |!a |!prescription |!from |!the |!health |!care |!provider.
|!When |!examining |!the |!prescription, |!which |!of |!the |!following |!would |!the |!nurse |!expect |!to
|!find |!documented? |!Select |!all |!that |!apply.
A) Name |!of |!the |!drug
B) Dosage |!of |!the |!drug
C) Route |!of |!drug |!administration
D) Times |!of |!drug |!administration
E) Licensed !|prescriber's |!signature
|!Ans: |!A, |!B, |!C, |!D, |!E
Feedback:
The |!prescription |!must |!contain |!the |!client's |!name, |!the |!name |!of |!the |!drug, |!the |!dosage, |!the
|!method |!and |!times |!of |!administration, |!and |!the |!signature |!of |!the |!licensed |!health |!care
|!provider |!prescribing |!the |!drug.
9. After |!teaching |!a |!group |!of |!nursing |!students |!about |!nonprescription |!drugs, |!the |!nursing
|!instructor |!determines |!that |!the |!teaching |!was |!successful |!when |!the |!students |!identify
|!which |!of |!the |!following? |!Select |!all |!that |!apply.
A) They |!require |!a |!licensed |!health |!care |!provider's |!signature.
B) They |!are |!referred |!to |!as |!over-the-counter |!drugs.
C) They |!can |!be |!taken |!without |!risk |!to |!the |!client.
D) They |!have |!certain |!labeling |!requirements.
E) They |!should |!be |!taken |!only |!as |!directed |!on |!the
|!label. |!Ans: |!B, |!D, |!E
Feedback:
Nonprescription |!drugs |!are |!often |!referred |!to |!as |!over-the-counter |!(OTC) |!drugs. |!They |!do
|!not |!require |!a |!prescription |!(a |!licensed |!health |!care |!provider's |!signature) |!but |!do |!not
|!come |!without |!risk |!to |!the |!client. |!The |!federal |!government |!has |!imposed |!labeling
|!requirements |!of |!OTC |!drugs |!and |!they |!should |!only |!be |!taken |!as |!directed |!on |!the |!label
|!unless |!under |!the |!supervision |!of |!a |!health |!care |!provider.
Page | ! 3 WWW.THENURSINGMASTERY.COM
, TESTBANK |!FOR |!ROACHES |!INTRODUCTORY |!CLINICAL |!PHARMACOLOGY |!11TH |!EDITION
10. A |!nursing |!student |!is |!reviewing |!information |!about |!the |!Controlled |!Substances |!Act
|!of |!1970. |!The |!student |!would |!expect |!to |!find |!which |!of |!the |!following |!as |!being
|!regulated |!for |!drugs |!classified |!as |!controlled |!substances? |!Select |!all |!that |!apply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
|!Ans: |!A, |!C, |!E
Feedback:
The |!Controlled |!Substances |!Act |!of |!1970 |!regulates |!the |!manufacture, |!distribution, |!and
|!dispensing |!of |!drugs |!classified |!as |!controlled |!substances. |!Elimination |!refers |!to |!the
|!excretion |!of |!drugs |!from |!the |!body, |!a |!pharmacokinetic |!activity. |!The |!act |!does |!not |!address
|!formulation |!of |!the |!drug.
11. When |!reviewing |!information |!about |!the |!Orphan |!Drug |!Program, |!which |!of |!the
|!following |!would |!the |!nurse |!expect |!to |!find? |!Select |!all |!that |!apply.
A) The |!program |!encourages |!the |!development |!and |!marketing |!of |!products |!to |!treat
|!rare |!diseases.
B) The |!program |!grants |!provisional |!approval |!with |!a |!written |!commitment |!from
|!the |!drug |!company |!to |!formally |!demonstrate |!client |!benefits.
C) The |!program |!provides |!for |!incentives, |!such |!as |!research |!grants, |!protocol
|!assistance, |!and |!special |!tax |!credits, |!to |!develop |!products |!to |!treat |!rare |!diseases.
D) The |!program |!grants |!7 |!years |!of |!exclusive |!marketing |!rights |!to |!the |!manufacturer
|!if |!approved.
E) The |!program |!accelerates |!approval |!of |!drugs |!based |!on |!preliminary |!evidence
|!before |!formal |!demonstration |!of |!client |!benefits.
Ans: |! A, |!C, |!D
Feedback:
The |!Orphan |!Drug |!Program |!encourages |!the |!development |!and |!marketing |!of |!products
|!used |!to |!treat |!rare |!diseases. |!The |!program |!provides |!incentives |!to |!encourage
|!manufacturers |!to |!develop |!orphan |!drugs, |!and |!if |!approved, |!the |!manufacturer |!has |!7
|!years |!of |!exclusive |!marketing |!rights. |!Accelerated |!programs |!involve |!provisional
|!approval |!and |!approval |!based |!on |!preliminary |!evidence.
Page | ! 4 WWW.THENURSINGMASTERY.COM
|! |! |! |!
PHARMACOLOGY 11TH EDITION
|! |! |!
1. A |!nursing |!instructor |!is |!preparing |!a |!teaching |!plan |!for |!a |!group |!of |!nursing |!students
|!about |!pharmacology. |!When |!describing |!this |!topic, |!the |!instructor |!would |!focus |!the
|!discussion |!on |!which |!of |!the |!following |!as |!an |!essential |!aspect?
A) Drug |!name
B) Drug |!class
C) Drug |!action
D) Drug |!source
|!Ans: | ! C
|!Feedback:
Pharmacology |!is |!the |!study |!of |!drugs |!and |!their |!action |!on |!living |!organisms. |!Thus, |!an
|!essential |!aspect |!of |!pharmacology |!is |!drug |!action. |!An |!understanding |!of |!the |!drug |!name,
|!drug |!class, |!and |!drug |!source |!is |!important, |!but |!the |!most |!critical |!aspect |!related |!to
|!pharmacology |!is |!how |!the |!drug |!acts |!in |!the |!body.
2. A |!nursing |!student |!is |!preparing |!to |!administer |!a |!prescribed |!drug |!to |!a |!patient. |!The
|!student |!reviews |!information |!about |!the |!drug |!and |!its |!actions. |!Which |!of |!the |!following
|!would |!be |!the |!best |!choice |!for |!obtaining |!this |!information? |!Select |!all |!that |!apply.
A) Nursing |!instructor
B) Nurse |!assigned |!to |!the |!patient
C) Clinical |!drug |!reference
D) Prescribing |!health |!care |!provider
E) Clinical |!pharmacist
|!Ans: |!C, |!E
Feedback:
Although |!the |!nursing |!student |!can |!ask |!the |!nursing |!instructor, |!the |!nurse |!assigned |!to |!the
|!patient, |!and |!the |!prescribing |!health |!care |!provider |!for |!information |!about |!the |!drug, |!the
|!best |!choices |!for |!drug |!information |!would |!include |!an |!appropriate |!drug |!reference |!and
|!the |!clinical |!pharmacist.
3. When |!describing |!the |!various |!types |!of |!medications |!to |!a |!group |!of |!nursing |!students,
|!a |!nursing |!instructor |!would |!identify |!which |!of |!the |!following |!as |!a |!source |!for
|!deriving |!medications? |!Select |!all |!that |!apply.
A) Plants
B) Synthetic |!sources
C) Mold
D) Minerals
E) Animals
|!Ans: |!A, |!B, |!C, |!D,
|!E
Feedback:
Medications |!are |!derived |!from |!natural |!sources, |!for |!example, |!plants, |!molds, |!minerals, |!and
|!animals, |!as |!well |!as |!created |!synthetically |!in |!a |!laboratory.
Page | ! 1 WWW.THENURSINGMASTERY.COM
,TESTBANK |!FOR |!ROACHES |!INTRODUCTORY |!CLINICAL |!PHARMACOLOGY |!11TH |!EDITION
4. Which |!of |!the |!following |!names |!may |!be |!assigned |!to |!a |!drug |!during |!the |!process
|!of |!development? |!Select |!all |!that |!apply.
A) Chemical |!name
B) Official |!name
C) Pharmacologic |!name
D) Trade |!name
E) Nonproprietary|!name
|!Ans: | ! A, |!B, |!D, |!E
Feedback:
Throughout |!the |!process |!of |!development, |!drugs |!may |!have |!several |!names |!assigned |!to
|!them |!including |!a |!chemical |!name, |!a |!generic |!(nonproprietary) |!name, |!an |!official |!name,
|!and |!a |!trade |!or |!brand |!name.
5. A |!drug |!may |!be |!classified |!by |!which |!of |!the |!following? |!Select |!all |!that |!apply.
A) The |!chemical |!type |!of |!the |!drug's |!active |!ingredient
B) The |!way |!the |!drug |!is |!used |!to |!treat |!a |!specific |!condition
C) The |!generic |!name |!of |!the |!drug
D) The |!trade |!name |!of |!the |!drug
E) The |!nonproprietary |!name |!of |!the |!drug
|!Ans: |!A, |!B
Feedback:
A |!drug |!may |!be |!classified |!by |!the |!chemical |!type |!of |!the |!active |!ingredient |!or |!by |!the |!way |!it
|!is |!used |!to |!treat |!a |!particular |!condition. |!Generic, |!trade, |!and |!nonproprietary |!refer |!to |!how
|!a |!drug |!is |!named.
6. A |!group |!of |!nursing |!students |!are |!reviewing |!information |!about |!the |!process |!of |!drug
|!development |!in |!the |!United |!States. |!The |!students |!demonstrate |!understanding |!of |!this
|!process |!when |!they |!identify |!that |!which |!of |!the |!following |!categories |!are |!assigned |!by
|!the |!Food |!and |!Drug |!Administration |!to |!newly |!approved |!drugs? |!Select |!all |!that |!apply.
A) Metabolite
B) Noncontrolled |!substance
C) Prescription
D) Nonprescription
E) Controlled |!substance
|!Ans: |!C, |!D, |!E
Feedback:
Once |!drugs |!are |!approved |!for |!use, |!the |!FDA |!assigns |!the |!drug |!to |!one |!of |!the |!following
|!categories: |!prescription, |!nonprescription, |!or |!controlled |!substance. |!Metabolite |!refers |!to
|!the |!inactive |!form |!of |!the |!drug. |!Noncontrolled |!substance |!is |!a |!term |!that |!is |!not |!used.
Page | ! 2 WWW.THENURSINGMASTERY.COM
,TESTBANK |!FOR |!ROACHES |!INTRODUCTORY |!CLINICAL |!PHARMACOLOGY |!11TH |!EDITION
7. Which |!of |!the |!following |!would |!be |!most |!important |!for |!the |!nurse |!to |!do |!to |!ensure |!the
|!safe |!use |!of |!prescription |!drugs |!in |!the |!institutional |!setting? |!Select |!all |!that |!apply.
A) Administering |!drugs
B) Monitoring |!clients |!for |!drug |!effects
C) Prescribing |!drugs
D) Evaluating |!clients |!for |!toxic |!effects
E) Educating |!clients/caregivers |!about |!drugs
|!Ans: |!A, |!B, |!D, |!E
Feedback:
In |!the |!institutional |!setting, |!the |!nurse's |!role |!to |!ensure |!safe |!use |!of |!prescription |!drugs
|!includes |!administering |!drugs, |!monitoring |!drug |!effects, |!evaluating |!for |!toxic |!effects, |!and
|!educating |!clients |!and |!caregivers |!about |!drugs.
8. The |!nurse |!is |!helping |!a |!client |!review |!a |!prescription |!from |!the |!health |!care |!provider.
|!When |!examining |!the |!prescription, |!which |!of |!the |!following |!would |!the |!nurse |!expect |!to
|!find |!documented? |!Select |!all |!that |!apply.
A) Name |!of |!the |!drug
B) Dosage |!of |!the |!drug
C) Route |!of |!drug |!administration
D) Times |!of |!drug |!administration
E) Licensed !|prescriber's |!signature
|!Ans: |!A, |!B, |!C, |!D, |!E
Feedback:
The |!prescription |!must |!contain |!the |!client's |!name, |!the |!name |!of |!the |!drug, |!the |!dosage, |!the
|!method |!and |!times |!of |!administration, |!and |!the |!signature |!of |!the |!licensed |!health |!care
|!provider |!prescribing |!the |!drug.
9. After |!teaching |!a |!group |!of |!nursing |!students |!about |!nonprescription |!drugs, |!the |!nursing
|!instructor |!determines |!that |!the |!teaching |!was |!successful |!when |!the |!students |!identify
|!which |!of |!the |!following? |!Select |!all |!that |!apply.
A) They |!require |!a |!licensed |!health |!care |!provider's |!signature.
B) They |!are |!referred |!to |!as |!over-the-counter |!drugs.
C) They |!can |!be |!taken |!without |!risk |!to |!the |!client.
D) They |!have |!certain |!labeling |!requirements.
E) They |!should |!be |!taken |!only |!as |!directed |!on |!the
|!label. |!Ans: |!B, |!D, |!E
Feedback:
Nonprescription |!drugs |!are |!often |!referred |!to |!as |!over-the-counter |!(OTC) |!drugs. |!They |!do
|!not |!require |!a |!prescription |!(a |!licensed |!health |!care |!provider's |!signature) |!but |!do |!not
|!come |!without |!risk |!to |!the |!client. |!The |!federal |!government |!has |!imposed |!labeling
|!requirements |!of |!OTC |!drugs |!and |!they |!should |!only |!be |!taken |!as |!directed |!on |!the |!label
|!unless |!under |!the |!supervision |!of |!a |!health |!care |!provider.
Page | ! 3 WWW.THENURSINGMASTERY.COM
, TESTBANK |!FOR |!ROACHES |!INTRODUCTORY |!CLINICAL |!PHARMACOLOGY |!11TH |!EDITION
10. A |!nursing |!student |!is |!reviewing |!information |!about |!the |!Controlled |!Substances |!Act
|!of |!1970. |!The |!student |!would |!expect |!to |!find |!which |!of |!the |!following |!as |!being
|!regulated |!for |!drugs |!classified |!as |!controlled |!substances? |!Select |!all |!that |!apply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
|!Ans: |!A, |!C, |!E
Feedback:
The |!Controlled |!Substances |!Act |!of |!1970 |!regulates |!the |!manufacture, |!distribution, |!and
|!dispensing |!of |!drugs |!classified |!as |!controlled |!substances. |!Elimination |!refers |!to |!the
|!excretion |!of |!drugs |!from |!the |!body, |!a |!pharmacokinetic |!activity. |!The |!act |!does |!not |!address
|!formulation |!of |!the |!drug.
11. When |!reviewing |!information |!about |!the |!Orphan |!Drug |!Program, |!which |!of |!the
|!following |!would |!the |!nurse |!expect |!to |!find? |!Select |!all |!that |!apply.
A) The |!program |!encourages |!the |!development |!and |!marketing |!of |!products |!to |!treat
|!rare |!diseases.
B) The |!program |!grants |!provisional |!approval |!with |!a |!written |!commitment |!from
|!the |!drug |!company |!to |!formally |!demonstrate |!client |!benefits.
C) The |!program |!provides |!for |!incentives, |!such |!as |!research |!grants, |!protocol
|!assistance, |!and |!special |!tax |!credits, |!to |!develop |!products |!to |!treat |!rare |!diseases.
D) The |!program |!grants |!7 |!years |!of |!exclusive |!marketing |!rights |!to |!the |!manufacturer
|!if |!approved.
E) The |!program |!accelerates |!approval |!of |!drugs |!based |!on |!preliminary |!evidence
|!before |!formal |!demonstration |!of |!client |!benefits.
Ans: |! A, |!C, |!D
Feedback:
The |!Orphan |!Drug |!Program |!encourages |!the |!development |!and |!marketing |!of |!products
|!used |!to |!treat |!rare |!diseases. |!The |!program |!provides |!incentives |!to |!encourage
|!manufacturers |!to |!develop |!orphan |!drugs, |!and |!if |!approved, |!the |!manufacturer |!has |!7
|!years |!of |!exclusive |!marketing |!rights. |!Accelerated |!programs |!involve |!provisional
|!approval |!and |!approval |!based |!on |!preliminary |!evidence.
Page | ! 4 WWW.THENURSINGMASTERY.COM
